Research
Online Inquiry

BMP Luciferase Reporter Plasmid

Cat.No: RESK-0373 Datasheet

Quantities:
- +
Product Details Related Products
Product Name BMP Luciferase Reporter Plasmid
Catalog No. RESK-0373
Description The BMP Luciferase Reporter Plasmid is a reporter gene plasmid developed by Alta DiagnoTech for detecting BMP transcriptional activity levels. BMPs (Bone Morphogenetic Proteins) can induce the differentiation of animal or human mesenchymal cells into bone, cartilage, ligament, tendon, and neural tissues. The BMP luciferase reporter plasmid is mainly applied in research on the BMP signaling pathway, drug research, and studies of gene regulation and function.
Intended Use Detection of BMP transcriptional activity levels.
BMP signaling pathway research.
Drug research.
Studies of gene regulation and function.
For research use only.
Principle / Technology This reporter plasmid is an engineered mammalian eukaryotic expression vector. Multiple BMP binding sites are inserted into the multiple cloning site, enabling high-sensitivity detection of BMP activation levels. Predicted binding sites for transcription factors other than the target factor have been appropriately mutated while preserving the original function, increasing the transcription factor binding specificity of the plasmid. The reduced plasmid size also makes the reporter plasmid easier to transfect.
Detection Method Luciferase reporter gene assay.
Sample Type Mammalian cells (e.g., human, mouse).
Sensitivity / LOD Enables high-sensitivity detection of BMP activation levels.
Specificity Predicted binding sites for transcription factors other than the target factors were appropriately mutated while preserving the original function, increasing the transcription factor binding specificity of the plasmid.
Reaction Conditions / Protocol Transient transfection is recommended; stable transfection is not recommended.
Transfection is performed as for a standard plasmid; refer to the instructions of the transfection reagent used.
Storage Conditions Store at -20°C.
Package Specifications 1 μg
Product Form Liquid.
Quality Control The full plasmid sequence is verified to be correct. Functional activity validation has not been performed; please refer to relevant literature.
Concentration Approximately 100 ng/uL.
Shipping Conditions Shipped with ice packs.
Regulatory / Compliance For research use only.
Compatibility A matched luciferase reporter plasmid negative control is available separately; a positive control should be selected by the user based on relevant literature.
Application Notes / Precautions For use in mammalian species only (e.g., human, mouse).
Transient transfection is recommended; stable inheritance of the plasmid after transfection is not advised.
The full plasmid sequence and the restriction sites flanking the binding-site insert are confidential; the transcription factor binding-site sequence and the plasmid sequencing primer sequences are provided in the manual supplied with purchase.
The 1 μg package is supplied in liquid form and is not intended for direct use; it is recommended to transform competent cells such as DH5α, culture, and re-prepare the plasmid to obtain larger quantities.
Recognition Site Multiple BMP binding sites inserted into the multiple cloning site.

For research use only, not for clinical use.

0
0

There is no product in your cart.